Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life-Threatening Hepatic Encephalopathy in a Septic Child With Sickle-Cell Disease: A Case Report.

Journal of clinical apheresis·2025

Same author

Upper Jaw Development After Lingual Laser Frenectomy and Myofuntional Therapy.

European journal of paediatric dentistry·2024

Same author

Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).

Trials·2024

Same author

Investigating strontium isotope linkage between biominerals (uroliths), drinking water and environmental matrices.

Environmental pollution (Barking, Essex : 1987)·2024

Same author

Triggers of migraine: where do we stand?

Current opinion in neurology·2022

Same author

May a comprehensive mineralogical study of a jackstone calculus and some other human bladder stones unveil health and environmental implications?

Environmental geochemistry and health·2021

Search research articles

Related Experiment Videos

[New way in diabetes prevention].

C Germinario¹, D Martinelli

¹Osservatorio Epidemiologico Regione Puglia.

Annali Di Igiene : Medicina Preventiva E Di Comunita

|September 9, 2008

Summary

Diabetes mellitus affects millions globally and in Italy, posing significant health risks. A new strategy using electronic databases and updated professional training aims to improve patient care and outcomes.

Area of Science:

Public Health
Endocrinology
Healthcare Management

Background:

Diabetes mellitus impacts 180 million worldwide, with 1.7 million in Italy, projected to double in 20 years.
In Italy, diabetes is a leading cause of chronic renal insufficiency, blindness, and increased cardiovascular mortality.
The Apulia Region faces significant diabetes-related hospitalizations, highlighting regional health burdens.

Purpose of the Study:

To outline a strategic approach for improving diabetes mellitus care in Italy.
To detail the evolution of diabetes care strategies from 1995 to the "Italian National Active Prevention Plane" in 2005.
To identify expected benefits and challenges of integrated diabetes management.

Main Methods:

Implementation of integrated care, patient involvement, and shared therapeutic protocols since 1995.

Related Experiment Videos

Redefinition of strategy in 2005 using electronic databases and systematic professional updates.

Focus on improved work organization, cost reduction, and enhanced patient care.

Main Results:

Expected benefits include better work organization, reduced costs, and improved patient care.
Key challenges involve the lack of short-term results during implementation.
Potential short-term outcomes include rapid patient identification and timely complication detection.

Conclusions:

The "Italian National Active Prevention Plane" offers a structured approach to diabetes management.
Systematic updates and electronic databases are crucial for effective diabetes care strategies.
Public health professionals are vital for organizing and ensuring the success of prevention plans.